Pharmaspectra Chair interviewed by The Pharma Letter – ‘Ever-improving data analytics drive better patient outcomes.’

Recently, Pharmaspectra Chair, Steve Kent, was interviewed by The Pharma Letter, which provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors.

In the article, Steve provides an expert view on the increasing impact of data in medicine.

“The landscape pharmaceutical companies navigate is becoming more complex,” said Steve. “Strong data is needed to help large pharma businesses navigate commercialization.”

Steve continues, “As well as this, the industry wants analytics overlaid on the raw data. One example of this would be Share of Scientific Voice (SoSV). Medical Affairs teams use information in order to drive their decision-making and actions. It is then important to measure the impact of those actions through a feedback loop called SoSV. SoSV measures the number of product mentions across scientific disseminations in a therapy area relative to alternatives. This analytics tool allows the Medical Affairs teams to measure, plan and communicate ways to increase their medical impact.”

To read the full article, go to www.thepharmaletter.com or complete your details on our ‘Request a demo’ page to discover more about Share of Scientific Voice.